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Immunity to Pancreas Disease in salmon 
Sonal Patel 
Institute of Marine Research, Bergen, Norway 
Pancreas disease (PD) caused by salmon pancreas disease virus (SPDV), also known as salmonid 
alphavirus (SAV), is a serious problem in the salmon farming industry in Northern Europe. Clinical 
cases are mostly seen at the post-smolt stages, and disease intensity depends on several factors 
such as SAV sub-type, size of fish, immune status, and whether the smolts were set to sea during 
autumn or spring season. Also, different SAV sub-types have shown varying geographic 
distribution. Studies covering infection of SAV and vaccination against SAV in salmonids, mostly 
salmon, but also trout have been carried out in freshwater stages, with very few studies in the sea-
water phase. SAV1 infection in freshwater seems to induce early induction of genes associated 
with immune and defence mechanisms, including genes involved in interferon I and II pathways, 
and MHC class I and II responses. Histopathological changes in heart and pancreas during early 
period, and in muscle at later time-points are evident upon SAV infection, and immune cells 
infiltrating these tissues can be detected. SAV neutralizing antibodies can be detected indicating 
induction of humoral responses. 
The general hypothesis is that the smolt and post-smolt stages are expected to be “leaky” and 
thus more susceptible to pathogens. Since, salmon often get PD during spring-summer period, 
which is very soon after sea-water transfer, especially for the post-smolts set out in spring, 
knowledge about how the biophysical parameters, along with physiological and immunological 
status of the salmon affects susceptibility to SAV infection during these stages is important. 
Understanding the mechanisms of SAV infection during a natural route of infection in sea water 
phase, and immune response to SAV at the cellular and molecular level will be valuable for future 
planning of preventive measures 
Presenting author:  Sonal Patel; Sonal.patel@imr.no  
 
  
  
The nasopharynx-associated lymphoid tissue of rainbow trout 
and the potential as a vaccine delivery site 
Scott LaPatra
1 
and Irene Salinas
2 
1Clear Springs Foods, Inc., Research Division, Buhl, Idaho, USA 
2Center for Evolutionary and Theoretical Immunology, Department of Biology,  
University of New Mexico, Albuquerque, New Mexico, USA 
The nasopharynx-associated lymphoid tissue (NALT) has only been identified in birds and mammals and is 
thought to be the first line of defense against airborne pathogens. However, the olfactory organ of aquatic 
vertebrates such as teleost fish is also exposed to waterborne pathogens. We hypothesized that NALT is an 
ancient and conserved arm of the mucosal immune system of all vertebrates, terrestrial and aquatic. Using 
rainbow trout as a model, we characterized the main features of teleost NALT at the cellular and molecular 
level. Trout NALT follows the main canonical features present in other fish mucosa-associated lymphoid 
tissues including diffuse lymphoid cell populations, a preponderant number of IgT B cells and IgT levels in 
mucus as well as a diverse associated bacterial community (microbiota). Our results reveal for the first time 
that NALT is an important arm of the mucosal immune system of fish.  
Nasal vaccines are commonly used in domestic and farmed terrestrial animals and humans. Nasal vaccines 
require small amounts of antigen and stimulate both local and systemic immune responses. Based on our 
findings we aimed to evaluate the effectiveness of two previously developed vaccines in rainbow trout, a 
live attenuated infectious hematopoietic necrosis virus vaccine (IHNV) and a killed enteric red mouth (ERM) 
bacterin. The nasal route was compared to the immersion and injection routes in a series of different 
experiments. Additionally, delivery of both vaccines into a single nare or each vaccine into separate nares 
was also tested. Challenge to live pathogens at 7 and 28 days post-vaccination revealed that delivery of 
IHNV into the left nare and ERM into the right nare is the most effective of all the vaccination regimes 
tested, including injection of IHNV and immersion with ERM vaccines. Our results demonstrate the nasal 
vaccines are novel and a potentially new way to effectively control aquatic infectious diseases.  
Presenting author: Scott LaPatra; scottl@clearsprings.com 
  
  
Control and treatment of parasitic diseases in Danish Aquaculture 
Niels Henrik Henriksen 
The Danish Aquaculture Organisation 
Within Europe there is no medicines licensed against fish parasites such as Ichthyobodo necator, 
Ichthyophthirius multifiliis and amoebae. Since the ban of malachite green, formaldehyde has 
been used widely as water disinfectant against these parasites. Due to the carcinogenic properties 
of formaldehyde Danish researchers have been looking for alternatives. One of the most 
promising substances has shown to be peracetic acid (PAA). PAA has proven effective in 
controlling several kinds of parasites on rainbow trout and in fact also Saprolegnia on eggs. 
However, the use of the substance is not as easy as formaldehyde. PAA degrades rapidly, 
especially in water rich in organic matter. Repeated or continuous dosaging is needed. 
Presenting author: Niels Henrik Henriksen; niels@danskakvakultur.dk 
 
  
  
Cellular immunity against ERM and furunculosis 
T. Yamaguchi1, G. Kato2, V. Soto-Lampe1, H. Miyazawa2, U. Fischer1* 
 
1Federal Research Institute for Animal Health, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany 
2Tokyo University of Marine Science and Technology, Japan 
Enteric red mouth (ERM) disease and furunculosis are important bacterial diseases in rainbow 
trout aquaculture. While ERM is caused by Yersinia ruckeri the causative agent of furunculosis is 
Aeromonas salmonicida. While a number of publications have clearly shown humoral immune 
responses to bacterial diseases in fish, little is known about the impact of cellular immunity. Cell-
mediated cytotoxicity is one of the options the immune system can mount against intracellular 
infections particularly in viral diseases. However, a facultative intracellular lifestyle has also been 
suggested for Y. ruckeri and A. salmonicida. 
Here we have used two approaches to investigate the role of cellular immunity in ERM and 
furunculosis: (1) adoptive transfer of immune cells from vaccinated donors followed by challenge 
of the recipients and (2) in vitro cell-mediated cytotoxicity of immune cells from vaccinated donors 
against bacterial infected target cells, respectively. Further, bacterin uptake by the gills has been 
studied for A. salmonicida. 
As for ERM we have isolated PBL from bath vaccinated clonal trout donors and transferred to 
naïve genetically identical clonal fish recipients followed by challenge of the latter with live Y. 
ruckeri bacteria. All fish that have received PBL from vaccinated donors survived the challenge 
infection while control fish injected with leukocytes from non-vaccinated trout exhibited high 
mortality. Flow cytometry analysis of recipient leukocytes suggest that CD8+ and IgT+ cells from 
donors have a preference to home to or to proliferate in the recipient gills. Transfer of memory B 
cells has been concluded from the fact that IgM titres were higher in Y. ruckeri infected recipients 
injected with immune cells from vaccinated donors when compared to control fish. While this is 
the first report on adoptive cellular transfer of immunity in a bacterial infection in fish, our data 
further suggest that immunity in ERM is rather conferred by IgM+ B cells.  
Concerning furunculosis, a new cell line matched in its MHC class I to our clonal trout has been 
established and intracellularly infected along with an MHC class I mismatched cell line with A. 
salmonicida bacteria. Cell-mediated cytotoxicity of leukocytes isolated from vaccinated donors 
was rather moderate and NK-like.  
In addition, we have performed A. salmonicida bacterin uptake studies in the gills. Our flow 
cytometry and histology data have shown that killed A. salmonicida bacteria are taken up by M-
like cells based on their lectin staining pattern and that antigen uptake took place in the direct 
neighbourhood of the interbranchial lymphoid tissue (ILT).  
Presenting author: Uwe Fisher, uwe.fischer@fli.bund.de 
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1Department of Animal Science, Aarhus University, Denmark 
2Danish Aquaculture, Silkeborg, Denmark 
3National Veterinary Institute, DTU, Denmark 
4S. B. Madsen Veterinary Service, Denmark 
5Department of Veterinary Disease Biology, University of Copenhagen, Denmark 
6Vaxxinova Norway, Bergen, Norway 
Despite vaccination by intraperitoneal injection with oil-adjuvanted vaccines against vibriosis and 
furunculosis, sea reared rainbow trout in Denmark often develop furunculosis and occasionally 
vibriosis during warm summer periods. This implies an excessive use of antibiotics and has also 
decreased some fish farmer’s confidence in the commercially available vaccine. This vaccine 
comprises Aeromonas salmonicida subspecies salmonicida and Vibrio anguillarum serotypes O1 
and O2a bacterins emulsified with mineral oil. The bacterin antigens are based on bacteria isolated 
from Atlantic salmon cultured outside Denmark.  
Vaccination and challenge trials performed under experimental conditions suggest that the 
commercial vaccine provides good protection against challenge with Aeromonas salmonicida 
when the fish are exposed to the bacteria by injection. However, the protection is far less 
significant when the fish are challenged by cohabitation with infected donor fish followed by 
elevation of the water temperature. The results demonstrate the importance of optimizing the 
challenge procedure for evaluation of vaccine efficacy under experimental conditions. In terms of 
Vibrio anguillarum the commercial vaccine failed to protect the fish against an serotype O2 isolate 
from diseased fish, suggesting that tailoring the antigen composition to Danish/local bacterial 
variants is needed. Serological examination of the vaccine induced antibody response in the fish is 
in progress aiming at evaluating the contribution of the humoral immune response to protection 
as well as at development of an in vitro tool for evaluation of vaccine potency.  
Presenting authors:  Helle F. Skal; hellef.skall@anis.au.dk 
 Niels Lorenzen; niels.lorenzen@anis.au.dk 
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1Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark 
2Vaxxinova Norway AS, Bergen, Norway 
2National Veterinary Institute, Technical University of Denmark, Denmark 
4Department of Animal Science, Aarhus University, Denmark 
Rainbow trout, Oncorhynchus mykiss were vaccinated by intraperitoneal (i.p.) injection with 
vaccines containing bacterin alone or bacterin supplemented with experimental vegetable oil-
based adjuvant or a paraffin oil adjuvant. The bacterin consisted of formalin killed bacteria of 
Aeromonas salmonicida subsp. salmonicida strain 090710-1/23 in combination with Vibrio 
anguillarum serotypes O1 and O2a.  Fish were challenged with the same bacterial strain of A. 
salmonicida either by i.p. or by applying a novel challenge method. Skin lesions were made by 
puncturing the caudal fin epidermis followed by layering the bacterial culture of A. salmonicida on 
the puncture site for 60 seconds. This challenge method mimics that rainbow trout in fish farms 
might be infected with A. salmonicida through injured epidermis (fin biting) and our new method 
resembles closely the natural infection route where bacteria gain access to fish through the 
lesions. The protection, antibody production and side-effects were examined during the trial. The 
bacterin administered with adjuvant elicited protection and antibody production that was 
dependent on the antigen concentration in the vaccine. The new infection model proved to be 
efficient in inducing a more natural disease progression in fish and a stable mortality. The method 
can differentiate efficacies of different vaccines with regard to adjuvant formulations and content 
of antigen. 
Presenting author:  Moonika Harhr Marana; mmarana@sund.ku.dk  
  
  
Real-time in vivo imaging of bioluminescent 
Aeromonas salmonicida in rainbow trout 
S. Bartkova, B. Kokotovic, I. Dalsgaard 
National Veterinary Institute, Technical University of Denmark, Denmark 
Aeromonas salmonicida susbp. salmonicida, the causative agent of the disease furunculosis, 
causes great problems in Danish sea reared rainbow trout (Oncorhynchus mykiss) production.  
Outbreaks occur repeatedly during elevated temperatures and fish harboring A. salmonicida can 
also be covertly infected. A crucial factor for preventing spread of furunculosis is therefore gaining 
more knowledge of the covert stage, which includes knowing the route of entry and dissemination 
of the pathogen in the fish. To determine this, one could trace the bacterium using in vivo 
bioluminescence imaging (BLI) that enables visualization and quantification of infections within the 
same animal over several time points. In this research BLI was used to follow the infection of a 
virulent Danish A. salmonicida isolate transformed with pAKgfplux1; a plasmid vector containing 
the gfpmut3a gene from Aequorea victoria and the luxCDABE operon from Photorhabdus 
luminescens. Since A. salmonicida pAKgfplux1 displayed similar growth and pathogenicity as the 
wild type A. salmonicida, the transformed bacterium could be used to illustrate a progression of 
an A. salmonicida infection. Fish were infected with A. salmonicida pAKgfplux1 through an 
immersion bath and followed over a 24 h period using an IVIS® Spectrum system. Results showed a 
pattern of favourable pathogen attachment sites, internal passageway and main exit site that will 
be shown and discussed in the presentation.  
Presenting author: Simona Bartkova; sibar@vet.dtu.dk  
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1Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark 
2National Veterinary Institute, Technical University of Denmark, Denmark 
Enteric redmouth disease (ERM) caused by the fish pathogen Yersinia ruckeri is a major threat to 
freshwater production of rainbow trout (Oncorhynchus mykiss) throughout all life stages but 
vaccination may be a way to control the disease. Injection vaccination of rainbow trout against Y. 
ruckeri infection has been shown to confer better protection compared to the traditionally applied 
immersion vaccination.  It may be hypothesized, based on experience from other vaccines, that 
adjuvants may increase the protective level of ERM injection vaccines even more.  
Controlled comparative vaccination studies have been made to investigate effects of the oil 
adjuvant MontanideTM ISA 763 A VG (Seppic) when added to an experimental Y. ruckeri bacterin 
(containing both biotype 1 and 2 of serotype O1). Duplicated tanks (2 × 100 fish per group) of fish 
(mean weight 19 g) were used and tested for protection of 1) non-vaccinated control fish, 2) fish 
injected with a commercial vaccine (AquaVac® Relera™), 3) fish injected with an experimental 
vaccine, 4) fish injected with an experimental vaccine + adjuvant and 5) fish injected with adjuvant 
alone.  
It was shown that injection of an experimental vaccine composed of formalin killed Y. ruckeri 
(biotype 1 and 2, serotype O1) (both adjuvanted and non-adjuvanted) conferred a high level of 
immunity to rainbow trout. Additional experiments using higher challenge dosages showed that 
the protection was increased by the adjuvant component which in itself induced protection. 
Injection of an experimental vaccine + adjuvant induced a higher level of antibody in serum, both 
before challenge and at day 21 following challenge, when compared to non-vaccinated control 
fish. Expression levels of immune-related genes were more prominent in spleen and liver than in 
head kidney, but no clear skewing of the immune response towards a Th1, Th2, Th17 or Treg type 
was seen.   
Presenting author:  Rzgar M. Jaafar; rezgarhadad@sund.ku.dk 
  
  
Selective manipulation of the gut microbiota 
improves immune status in vertebrates 
Jorge Galindo-Villegas 
Department of Cell Biology and Histology, Faculty of Biology, University of Murcia, Spain. 
All animals develop in association with complex microbial communities. It is now well established 
that commensal microbiota is essential for the correct functionality of each organ in the host. 
Particularly, the commensal gastro-intestinal microbiota (CGIM) is a key factor for development, 
immunity and nutrient conversion, rendering them bio-available for various uses. Thus, nutritional 
inputs generate a positive loop in maintaining host health and are essential in shaping the 
composition of the CGIM communities. Probiotics, which are live exogenous microorganisms, 
selectively provided to the host, are a promising concept for manipulating the microbiota and thus 
for increasing the host health status. Nevertheless, most mechanisms induced by probiotics to 
fortify the immune system are still a matter of debate. Alternatively, prebiotics, which are non-
digestible food ingredients, can favor the growth of specific target groups of CGIM. Several 
metabolites are produced by the CGIM, one of the most important are the short-chain fatty acids 
(SCFAs), which emerge from the fermentation of complex carbohydrates. SCFAs have been 
recognized as key players in triggering beneficial effects elicited by simple diffusion and by specific 
receptors present thus far only in epithelial cells of higher vertebrates at different GI locations. 
However, both strategies have shown to provide resistance against pathogens during periods of 
high stress. In fish, knowledge about the action of pro- and prebiotics and SCFAs is still limited. 
Thus, in this talk, I will briefly summarize the mechanisms described on this topic for higher 
vertebrates and discuss why many of them may operate in the fish gut representing a model for 
different mucosal tissues. 
Keywords: Fish, Host-Microbe, Humans, Immunity, Microbiota, Prebiotics, Probiotics, SCFA, 
Vertebrates. 
Presenting author:  Jorge Galindo-Villegas, jorge-galindo@usa.net  
  
  
VHS virus – present situation 
Niels Jørgen Olesen
1
 and Helle Frank Skall
2 
1 National Veterinary Institute, Technical University of Denmark, Denmark 
1Department of Animal Science, Aarhus University, Denmark 
Besides being the EU Reference Laboratory for Fish Diseases the fish health section at DTU is also 
appointed as the OIE reference laboratory for VHS and has as such obligations to keep updated on 
the emergence and evolution of VHS worldwide. 
Geographic distribution:  
VHSV can be divided into 4 genotypes and at least 8 subtypes and there is a close linkage between 
genotypes, geographic range and affected fish species. VHS is still only reported from the Northern 
hemisphere- and while countries like Denmark, Norway and England have freed themselves for 
VHS, several countries are still struggling with the disease. An update on the recent VHS outbreaks 
in rainbow trout in Iran, in olive flounder in Korea, in wrasse in Scotland, in turbot in Turkey, in a 
number of fish species in the great lakes in USA and Canada, and a general overview of the 
worldwide distribution of the disease will be given. 
Virus evolution:  
Recent studies indicate that only a few amino acid changes in the structural proteins of VHSV can 
change the virulence patterns significantly, thereby coming closer to assessing the risk of none to 
low virulent viruses becoming high virulent. Virulence factors both depend on the ability of VHSV 
to enter a cell and on the speed and efficiency of virus replication in the cells. Apparently the viral 
nucleocapsid protein plays a very important role for the later and seems to be the target for 
determination of a virulence marker.  
Presenting author:  Niels Jørgen Olesen; njol@vet.dtu.dk 
 
  
  
Can the Choice of Adjuvant Direct T-cell Responses, 
Minimize Adverse Effects and Still Confer Protection? 
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1Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark 
2 Vaccine Research & Development, Infectious Disease Immunology, Statens Serum Institut  
3 Department of Basic Sciences and Aquatic Medicine, Norwegian University of Life Sciences 
For the past two decades, mineral oils have been utilized as a potent adjuvant when formulating 
injection furunculosis vaccines for intraperitoneal administration in aquaculture of salmonid 
fishes. Over this period, several field, as well as laboratory studies have demonstrated that these 
adjuvants improve protection against furunculosis, caused by Aeromonas salmonicida subsp. 
salmonicida. However, studies have also demonstrated a range of severe adverse effects 
associated with the use of mineral oils in fish vaccine formulations, a consequence that warrants 
further exploration of alternatives to the current status quo. 
Working with injection vaccines against furunculosis in rainbow trout, this current project aims to 
shed light on two main questions:  
1. Considering a vaccine formulated with mineral oil as the benchmark, would it be 
possible to obtain a level of protection equal to, or higher than, that benchmark, while 
at the same time reducing the adverse effects, through the use of adjuvants with a 
higher expected safety profile?  
2. Could the use of specific adjuvants help to direct the T-cell response towards specific 
Th-profiles, potentially proving one to be superior with regards to protection?  
Three formulations of A. salmonicida bacterin with either CpG oligodeoxynucleotides, Freund’s 
incomplete adjuvant or cationic adjuvant formulation 01 (CAF01) were prepared to approach 
these questions. Along with relevant control groups, the vaccine groups are now subjected to an 
experimental protocol assessing the nature of the respective leukocyte responses, adverse effects, 
antibody responses, as well as protection from infection of each group. Hopefully, the results will 
provide valuable insight into the optimal induction of the immune response of rainbow trout, and 
help to identify safer alternatives to the current adjuvants, paving the way to the formulation of 
the next generation of furunculosis vaccines for commercially farmed rainbow trout.  
Presenting Author:  Kasper Rømer Villumsen; krv@sund.ku.dk 
  
  
Antigen uptake in zebrafish (Danio rerio) 
L.v.G. Jørgensen, F. Mehrdana, P.W. Kania, M.H. Larsen, D. Frees and K. Buchmann 
Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark 
In aquaculture, immersion-vaccines are routinely used in rainbow trout against Yersinia ruckeri 
(Yr). The vaccines consist of dead bacteria (bacterin) and following immersion lasting at least 30 
seconds, rainbow trout take up the dead bacteria and following 400 degree days they acquire a 
level of protection. We have used zebrafish as a model organism to study uptake mechanisms and 
subsequent transport in fish. A gene-modified Yr, developed to constitutively express GFP (green 
fluorescent protein), was used for bacterin production. Transparent zebrafish (Tra:nac) were 
immersed in this bacterin for up to 30 minutes. Samples were taken after 1 min, 15 min, 30 min, 2 
h, 12 h and 24 h. At each sample point two fish were used for live imaging using a 
stereomicroscope with UV filters, and three fish sampled for immunohistochemistry (IHC). Results 
showed that bacteria initially were visible in scale pockets, sometimes on the skin, in the 
esophagus, in the intestine and in a few instances on the fins. However, within two hours Yr-
antigens were visible in the spleen and within 24 hours also in liver and kidney. Bacteria were 
found to be associated with the gills but were not seen penetrating gill epithelium or inside cells of 
the gills. These results are in alignment with studies conducted on rainbow trout, and zebrafish 
may therefore serve as a suitable model for rainbow trout. The next step in this investigation will 
include the cellular mechanisms responsible for antigen transport.  
Presenting author:  Louise von Gersdorff Jørgensen; lvgj@sund.ku.dk 
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An overview of our in-house developed zebra fish model of inflammatory bowel disease (IBD), a 
chronic human disease resulting in significantly reduced quality of life, will be given. A number of 
different techniques have been employed in order to correctly characterize the model, including 
quantitative-real time PCR (qPCR), Optical Projection Tomography (OPT), goblet cell counting and 
protein expression by 2-dimensional gel electrophoresis. The findings will be related to other 
inflammation studies using experimental animals, and the advantages as well as the pitfalls of the 
model will be discussed. Finally, some thoughts regarding the translatability of the obtained data 
to the human condition are presented. 
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 Infections with Ichthyophonus sp. cause a serious and granulomatous disease in rainbow trout 
Oncorhynchus mykiss affecting several organ systems. The pathology associated with the parasite 
infection has been described, but no details on specific cellular reactions have been presented. 
This study was conducted to investigate the cellular immune reaction towards the parasite. By 
employing immunohistochemical techniques we were able to evaluate to what extent IgD, IgT and 
IgM positive lymphocytes were involved in the reaction. Samples from heart, liver and head kidney 
were collected from naturally infected rainbow trout. Positive cells were generally present in all 
organs. However, it was found that a wide zone around the parasite was devoid of positive cells. 
This suggests that the parasite induces some immune-depression in the host, a hypothesis which 
must be further investigated.  
Presenting author:  Azmi Al-Jubury; azmi@sund.ku.dk  
  
  
Inducing protection from Tetrahymena infection in guppies:  
a model for systemic parasitosis 
Dina Zilberg 
Ben Gurion University, Israel 
Tetrahymena is a protozoan parasite which infects a wide range of fish species, yet most 
commonly reported from guppies, in which its effect appears to be the most devastating. Infection 
appeared to initiate through the skin, creating lesions which extended into the musculature. The 
parasite then spreads to all internal organs and gills, through tissue destruction and the 
circulation. Infection affects all internal organs, brain, eye and gills (Pimenta-Leibowitz and Zilberg 
2009). Inflammatory response was negligible in guppy (as well as in platy and angelfish; 
Acanthopterygii superorder), yet it was evident in goldfish and koi (Ostaryophysi super order; 
Sharon et al., 2014). 
Advantages of the infection model include the feasibility to easily culture Tetrahymena in vitro, yet 
regular passage through fish is needed to maintain its pathogenicity (Pimenta Leibowits et al., 
2009). Guppies can be available at large numbers (as are regularly sorted out in commercial farms 
or can be easily produced) and small scale systems are needed for experimentation. Being able to 
adapt to various salinities, guppy can be used to study both marine and freshwater parasites. 
Guppies were successfully immunized against Tetrahymena by intra peritoneal injection along 
with adjuvant (Chettri et al., 2009) and antibody response was demonstrated (Sharon et al., 2015). 
To evaluate the potential of oral immunization, anal delivery of the antigen was attempted, but it 
did not lead to protection and resulted in low to no increase in antibody titer (Sharon et al., 2015). 
Infection with Tetrahymena was used to evaluate the effect of dietary supplementation with 
Labosphera incisa, a  microalgae which produces high levels of arachidonic acid, and its dihomo-γ-
linolenic acid (DGLA) – producing mutant. Their application was demonstrated to reduce infection 
level and associated mortality from Tetrahymena (Khozin-Goldberg et al., 2006; unpublished). 
Tetrahymena infection was also used to evaluate the effect of different commercial diets on fish 
health (Sharon et al., 2014).  
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enteric red mouth disease in rainbow trout – field trials 
Jacob G. Schmidt and Kurt Buchmann 
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Enteric red mouth disease (ERM) is caused by the bacterium Yersinia ruckeri, and is one of the 
most common and costly diseases in rainbow trout aquaculture. An effective vaccine is available, 
and vaccination of fry at around 5 g is common practice on the fish farms. However, the vaccine 
only offers protection for a few months. This protection can be prolonged by a booster 
vaccination, which is recommended 4 months after the first vaccination. However, at this time the 
fish have increased their size approximately tenfold and vaccination is consequently so expensive 
that fish farmers are reluctant to administer a booster vaccination. It was speculated that a diluted 
booster vaccine could be sufficiently effective if exposure time was increased. Subsequent 
laboratory experiments showed that the recommended 1:10 diluted booster for 30 s provided 
superior protection to a 1:1000 or 1:2000 diluted booster for 1-2 h (Chettri et al 2015). However, 
the dilute booster still significantly improved survival following challenge with Y. ruckeri compared 
to fish receiving no booster, and could be a realistic alternative for the fish farmer. 
To verify these results in a natural situation, field trials were set up at two conventional fish farms, 
which both experienced regular outbreaks of ERM. A more detailed explanation of the experiment 
and the results will be presented at the workshop. In short, one of the two fish farms experienced 
an ERM outbreak two months after the first vaccination, but before the dilute booster was 
administered. In this case about 5% of unvaccinated fish in a control pond died, while mortality 
was almost negligible in the ponds with vaccinated trout. Thus, the vaccine worked very well. 
There were no more ERM outbreaks on this farm. The fish were dilute booster vaccinated 12 
weeks after the first vaccination. On the other farm there was an ERM outbreak less than a week 
after the booster vaccination was administered. While the first vaccination still provided some 
protection (only approximately 1% of the fish died), there was no mortality in the booster 
vaccinated fish. 
Presenting author:  Jacob Günther Schmidt; jasch@sund.ku.dk 
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establishment of challenge model and long term pathogenetic study 
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National Veterinary Institute, Technical University of Denmark, Denmark 
During autumn 2013, abnormal mortality was observed in some hatcheries producing rainbow 
trout in western Norway. The fish, 30-100g, showed signs of a novel disease characterized by 
circulation failure, pale viscera, anaemia and liquid (ascites) in the abdominal cavity. Haematocrit 
analysis confirmed severe anaemia. The histopathological examination revealed inflammation of 
the heart and red muscle and liver necrosis. Moderate to high mortalities have been observed.  
Extended microbiological examination performed at the National Veterinary Institute (NVI) in Oslo 
ruled out known pathogens, while pyrosequecing analysis detected the viral genome of new 
aetiological agent called virus Y. Further studies have shown the virus belongs to the orthoreovirus 
family and is distantly related to PRV (piscine orthoreovirus) that most likely is involved in Heart 
and Skeletal Muscle Inflammation (HSMI) in Atlantic salmon. 
A cooperative project between DTU-VET in Copenhagen, NVI and NMBU in OSLO was initiated in 
order to: 
• Assess whether this new virus represent a new high pathogenic pathogen for farmed 
Rainbow trout in Europe 
• Investigate disease pathogenesis. 
 In cohabitation trials, naïve Rainbow trout were exposed to shedders injected IP with blood 
pellets from infected fish.  
Sampling was carried out at defined time points for 14 weeks.  
The virus load in various organs was assessed by RT-qPCR analysis in shedders and cohabitants 
revealing a fast and active transfer of virus from shedders to cohabitants.  
During the second half of the trial it was possible to observe a certain clearance process of the 
virus which occurred early in the shedders and later in the cohabitants. 
Very little mortality and few clinical signs were observed. 
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Two candidate adjuvants were tested with a commercial ERM dip vaccine (AquaVac™ Relera, MSD 
Animal Health) for rainbow trout in an experimental design compatible with common vaccination 
practices at farm level, i.e. immersion of fish in vaccine (±adjuvant) for 30 s. The adjuvants were 
the commercial product Montanide™ IMS 1312 VG PR (SEPPIC), and a soluble and ≥98% pure β-
glucan from yeast (Saccharomyces cerevisiae) (Sigma-Aldrich). Hence, five experimental groups in 
duplicate were established and exposed to vaccine and adjuvants in the following combinations: 
AquaVac™ Relera (alone); AquaVac™ Relera + Montanide™; AquaVac™ Relera + β-glucan; 
Montanide™ (alone); and β-glucan (alone). Approximately 450 degree days post-vaccination, the 
fish were bath-challenged with live Yersinia ruckeri to produce survival curves. Blood, skin and gills 
were sampled at selected time points during the course of the experiment to test for plasma Ab 
levels and lysozyme activity, and the regulation of immune relevant genes and cells in external, 
mucosal tissues. Preliminary results show 96% to 100% survival of vaccinated fish with and 
without any of the two adjuvants, whereas unvaccinated controls and fish exposed to β-glucan 
alone experienced 58% and 60% survival, respectively (calculated at day 24 post-challenge). 
Montanide™ alone gave rise to an intermediate level of 72% survival. Lysozyme activity levels in 
plasma were markedly elevated at day 3 and day 24 post-challenge in fish exposed to Montanide™ 
alone or β-glucan alone compared to fish from any of the three vaccinated groups.  
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